Pediatric ESAP 2017-2018
Course Description

The Pediatric Endocrine Self-Assessment Program (Pediatric ESAP™) is a self-study curriculum specifically designed for endocrinologists seeking initial certification or recertification in pediatric endocrinology, program directors interested in a training instrument, and clinicians seeking a self-assessment and a broad review of pediatric endocrinology. Pediatric ESAP 2017-2018 consists of 100 multiple-choice questions in all areas of pediatric endocrinology, diabetes, growth, and metabolism. There is extensive discussion of each correct answer and references.

Pediatric ESAP is updated with brand-new questions every other year.

Learning Options
Assess your clinical knowledge through different learning modes:

  • P-ESAP 2017-18 Learning Mode: This is the "traditional" ESAP. Answer 120 questions and receive immediate feedback and view the detail answer rationale. 
  • Mock Exam Mode: Perfect for simulating an exam. Retake this mock exam as often as you like and each time the questions will be re-organized. Feedback will be provided after completion of the exam.
    • Topical Learning Mode: Within Mock Exam Mode, you have the option to create your own exams by choosing the topic(s) to be included

METHOD OF PARTICIPATION
This enduring material is presented online and in print format. The estimated time to complete this activity, including review of material, is 40 hours. 
Target Audience
Pediatric ESAP is a self-study curriculum aimed at physicians seeking certification or recertification in pediatric endocrinology, program directors interested in a testing and training instrument, and clinicians seeking a self-assessment and a broad review of pediatric endocrinology.
Learning Objectives

Upon completion of this educational activity, participants will be able to:

  • Recognize clinical manifestations of pediatric endocrine, growth, and metabolic disorders and select among current options for diagnosis, management, and therapy.
  • Identify risk factors for endocrine and metabolic disorders in pediatric patients and develop strategies for prevention.
  • Evaluate pediatric endocrine and metabolic manifestations of systemic disorders.
  • Use current, evidence-based clinical guidelines and treatment recommendations to guide diagnosis and treatment of pediatric endocrine and metabolic disorders.
Accreditation Statement
This online activity is no longer available for CME credit. Learners who have purchased Pediatric ESAP 2017-2018 may access this online component as an educational resource only.
Faculty and Disclosures

Rachel I. Gafni, MD - Program Chair (2014-2015)
Bethesda, Maryland

Andrew J. Bauer, MD
Director, The Thyroid Center
Children's Hospital of Philadelphia
Associate Professor of Pediatrics
Perelman School of Medicine
University of Pennsylvania

Mark DeBoer, MD, MSc, MCR
Associate Professor of Pediatrics
University of Virginia School of Medicine

Alison M. Boyce, MD
Bethesa, Maryland

Reema L. Habiby, MD
Assistant Professor of Pediatrics
Northwestern University Feinberg School of Medicine

Ann & Robert H. Lurie Children’s Hospital of Chicago

Oksana Lekarev, DO
Assistant Professor of Pediatrics
New York-Presbyterian Hospital
Weill Cornell Medical College

Bradley S. Miller, MD, PhD
Associate Professor of Pediatrics
University of Minnesota Masonic Children’s Hospital

Paola A. Palma Sisto, MD
Associate Professor of Pediatrics
Connecticut Children’s Medical Center
University of Connecticut School of Medicine

Liuska M. Pesce, MD
Clinical Associate Professor
Pediatric Thyroid Clinic Director
Stead Family Department of Pediatrics
Division of Pediatric Endocrinology and Diabetes
University of Iowa

Lawrence Silverman, MD
Goryeb Children’s Hospital
Atlantic Health System

Paul S. Thornton, MD
Medical Director, Diabetes and Endocrinology
Director, Congenital Hyperinsulinism Center
Cook Children’s Medical Center

Abbie L. Young, MS, CGC, ELS(D)
Medical Editor

STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s ESAP Faculty Working Group.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The faculty reported the following relevant financial relationships during the content development process for this activity: Rachel I. Gafni, MD, employer receives research support from Shire Pharmaceuticals and spouse is partner owner of the Surgery Center of Bethesda as well as the Orthopedics Center. Alison M. Boyce, MD, employer receives research support from Amgen. Bradley S. Miller, MD, PhD, is a consultant and is on the Advisory Board for Abbvie, Ferring, Novo Nordisk, Pfizer, Sandoz, and Versartis. He has also received research funding from Alexion, BioMarin, Eli Lilly, Endo Pharmaceuticals, Genentech, Novo Nordisk, Tolmar and Versartis. Liuska Pesce, MD, spouse is a consultant for Vidas Diagnostics. Lawrence Silverman, MD, is a consultant/advisor for Opko Biologics, Endo Pharmaceuticals, Novo Nordisk, and Abbvie,is a contracted researcher for Novo Nordisk and Versartis and is a speaker for Abbvie. Paul S. Thornton, MD, is an investigator from Endo, Roche and Ascendis. 

The following committee members reported no relevant financial relationships: Andrew J. Bauer, MD; Mark DeBoer, MD, MSc, MCR; Reema Habiby, MD; Oksana Lekarev, DO; Paola A. Palma Sisto, MD.

The medical editor for this program, Abbie L. Young, MS, CGC, ELS(D), reported no relevant financial relationships.

The Endocrine Society staff associated with the development of this program reported no relevant financial relationships.

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT

This activity is not supported by educational grant(s) or other funds from any commercial supporter.

Summary
Availability:
Retired
Cost:
Member: $250.00
Non-Member: $350.00
In-Training Member: $199.00
Resident Member: $250.00
Resident Non-Member: $250.00
Credit Offered:
No Credit Offered
Contains:
Recommended
   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Android App Download IOS App Download Powered By